(R,E)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid, 97.0%, 5g

3-cyclopropyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine dihydrochloride, 95.0%, 250mg

4-Bromo-1-fluoro-2-(2,2,2-trifluoroethyl)benzene, 95.0%, 1g

tert-Butyl 3-chloroazetidine-1-carboxylate, 98%, 250mg

2-(4-Nitrophenyl)acetonitrile, 97.0%, 25g

3,4-Difluorobenzoic acid, 98.0%, 500g

Methyl-thiophen-2-ylmethyl-ammonium; chloride, 95.0%, 1g

4-Piperidin-1-ylmethyl-phenylamine, 95.0%, 5g

Polvo de manganeso, bajo contenido de oxígeno 99,8+% 125-500 micrones 250 g

Methyl 5-(3-fluorophenyl)isoxazole-3-carboxylate, 1g

1-(3-Amino-4-methoxyphenyl)ethanone, 95.0%, 1g

2-(1-{[(tert-Butoxy)carbonyl]amino}cyclopropyl)acetic acid, 95%, 10g

11-Oxa-2,7,9-triazadodec-7-enoic acid, 3-carboxy-10-oxo-12-phenyl-8-[[(phenylmethoxy)carbonyl]amino]-, 1-(9H-fluoren-9-ylmethyl) ester, (3S)-, 100mg